Physician profile
Herschl B Silberman
NPI 1124096706
$12,098.85
in general payments reported to CMS, 2019-2025
17 companies · $2,616 in 2025
The $2,616 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $19.06 · 2021: $29.23 · 2022: $2,354 · 2023: $5,219 · 2024: $959 · 2025: $2,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,894 · Food and Beverage: $3,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,893.54 |
| Food and Beverage | $3,901.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $6,518.07 | 2022-2023 | Indigo System, Penumbra Coil 400, Penumbra System |
| Abiomed | $2,637.99 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $700.53 | 2019 | |
| Abbott Laboratories | $460.45 | 2019-2025 | Dragonfly Opstar, Esprit, Xience Sierra |
| Medtronic, INC. | $408.74 | 2023-2025 | Corevalve Evolut R, In.Pact Admiral, Claria Mri Quad Crt-D Surescan |
| Boston Scientific Corporation | $250.18 | 2021-2024 | Avvigo Guidance System |
| Philips North America LLC | $247.96 | 2022 | |
| Shockwave Medical, INC | $241.05 | 2025 | |
| Cvrx, INC. | $197.64 | 2025 | Barostim Neo System |
| Terumo Medical Corporation | $105.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.87 | 2024 | |
| Novartis Pharmaceuticals Corporation | $64.82 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $60.83 | 2022 | |
| Canon Medical Systems USA, INC. | $54.37 | 2024 | General Device(S) |
| Medtronic Vascular, INC. | $19.06 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.51 | 2025 | Lokelma |
| Amgen INC. | $14.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herschl Silberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.